Short answer
Nutex Health Inc. (NUTX) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Nutex Health announced second-quarter results for the period ended June 30, 2026.
Nutex Health Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Nutex Health announced second-quarter results for the period ended June 30, 2026
- Financial and operating details are contained in Exhibit 99.1, the accompanying press release
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue fell 13.6% to $210.8M, despite hospital visits rising 9.6% to 49,962, indicating reimbursement and revenue-mix pressure
- Net income attributable to Nutex reached $65.8M versus a $17.7M loss, with diluted EPS $9.38 versus $(2.95)
- Six-month operating cash flow rose to $109.7M, while cash reached $205.2M and long-term debt remained low at $31.1M
- $52.3M reduction in contract-services expense from HaloMD and CMS fee changes materially boosted profitability
- Management expects normalized contract-services expenses to decline approximately 25-30% prospectively and plans three hospital openings later this year
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Nutex Health Inc. 8-K filings
Get the next NUTX 8-K as it lands
Follow NUTX for push alerts, or ask the research agent what this filing means.